Process validation in pharma: what it is, why it matters

Process validation is the documented evidence that your manufacturing process produces a consistent product, batch after batch, year after year. It sounds dry. It is. But it's also the spine of every pharmaceutical approval, because regulators don't want to know that the batch they're reviewing today is good. They want proof the batch you ship in 2031 will be just as good.

The three FDA lifecycle stages

FDA's 2011 process validation guidance laid out three stages, and almost every modern pharma manufacturer organizes their validation work around them.

Stage 1: Process Design. You define how the process should work, based on the science of the product. What's the API doing? What's the equipment doing? What environmental conditions matter? You produce a process design document and a control strategy.

Stage 2: Process Qualification. You prove on paper that the design works in practice. This is where IQ-OQ-PQ live: Installation Qualification (the equipment is installed correctly), Operational Qualification (it operates in the right ranges), and Performance Qualification (it produces a product that meets specs).

Stage 3: Continued Process Verification. Once you're in commercial production, you keep monitoring. Every deviation, every trend, every shift in raw material variability gets logged and analyzed. Validation is not a one-time event.

Validation types you'll see in audits

Process validation overlaps with related validation activities. The most common ones in a pharma audit:

• Cleaning validation: proves your equipment cleaning removes residues to acceptable limits. Critical in multi-product facilities.
• Analytical method validation: proves your QC tests measure what they claim to measure. Compliance with ICH Q2(R2).
• Equipment qualification: the IQ-OQ-PQ chain on every piece of GMP-relevant kit.
• Computerized system validation (CSV): proves your batch records, MES, and ERP systems handle data correctly.

Where validation usually goes wrong

Two recurring patterns in audit findings. The first is the documentation gap: the team did the right thing on the line, but the batch record doesn't capture it. From an audit perspective, undocumented work didn't happen.

The second is the deviation that wasn't escalated. Operator notices something off, fixes it, doesn't log it. A year later it shows up as a trend, but by then there's no record of when it started or how it was handled. That's the kind of finding that triggers a 483 observation.

Validation in the packaging line

Packaging is where validation gets tested in practice. Every blister sealing line, cartoner, serialization unit and labeling station has to be qualified before commercial production. We run full IQ-OQ-PQ on every line and document the lifecycle from day one to retirement.

The interesting work happens at scale. A line that runs 30,000 wallets a shift accumulates a lot of variability data. The cleaning cycle that worked in qualification might drift over six months. The label printer that hit spec in OQ might lose alignment after a roller change. Continuous monitoring is what catches that before it shows up in an inspection.

If you're picking a packaging partner

Don't ask whether they have validated processes. Everyone says yes. Ask for the last continuous process verification report. Ask how many deviations they had last quarter and how they closed them. Ask what their longest-running validated process is and how the protocol has evolved.

If you want to see ours, drop us a line. We'll walk you through a recent qualification on one of our cold seal lines.